HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA’s prayer is answered

Executive Summary

Generic Pharmaceutical Association urges Pharmaceutical Research & Manufacturers of America to discontinue ad campaign entitled "Pray For A Miracle." Ad "shamelessly exploits the photograph of a critically ill child" and "serves no purpose in advancing the debate regarding Hatch/Waxman," GPhA says in Sept. 20 letter to PhRMA. Ad ran in the Washington Post Sept. 18...

You may also be interested in...



The best advertising is free

PhRMA defends "Pray for a Miracle" ad campaign in response to Sept. 20 letter from Generic Pharmaceutical Association (1"The Pink Sheet" Sept. 23, In Brief). "The ad accurately points out that the legislation you champion would reduce incentives for the discovery of new medicine," PhRMA President Alan Holmer told GPhA in a Sept. 24 letter. "Generic drugs will offer nothing to those patients whose chances for a cure would decline if that legislation were to pass"...

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS040520

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel